Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
01 July 2010Website:
http://www.xtantmedical.comNext earnings report:
01 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 97 min agoDividend
Analysts recommendations
Institutional Ownership
XTNT Latest News
BELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that management will participate in two upcoming investor conferences:
Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q1 2023 Earnings Conference Call May 4, 2023 9:00 AM ET Company Participants Matt Steinberg - IR Sean Browne - CEO Scott Neils - CFO Conference Call Participants Chase Knickerbocker - Craig-Hallum Kyle Rose - Canaccord Genuity Operator Greetings. You're welcome Xtant Medical's Q1 2023 financial results call.
What type of business is Xtant Medical Holdings?
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
What sector is Xtant Medical Holdings in?
Xtant Medical Holdings is in the Healthcare sector
What industry is Xtant Medical Holdings in?
Xtant Medical Holdings is in the Medical Devices industry
What country is Xtant Medical Holdings from?
Xtant Medical Holdings is headquartered in United States
When did Xtant Medical Holdings go public?
Xtant Medical Holdings initial public offering (IPO) was on 01 July 2010
What is Xtant Medical Holdings website?
https://www.xtantmedical.com
Is Xtant Medical Holdings in the S&P 500?
No, Xtant Medical Holdings is not included in the S&P 500 index
Is Xtant Medical Holdings in the NASDAQ 100?
No, Xtant Medical Holdings is not included in the NASDAQ 100 index
Is Xtant Medical Holdings in the Dow Jones?
No, Xtant Medical Holdings is not included in the Dow Jones index
When does Xtant Medical Holdings report earnings?
The next expected earnings date for Xtant Medical Holdings is 01 August 2024